AI assistant
CVS HEALTH Corp — Director's Dealing 2020
Apr 3, 2020
29875_dirs_2020-04-03_1f170d35-3405-4e90-a539-db35e37ccb7a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2020-04-01
Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-01 | Common Stock | F | 681 | $58.34 | Disposed | 11321.2554 | Direct |
| 2020-04-01 | Common Stock (restricted) | A | 7713 | $58.34 | Acquired | 20204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-01 | Stock Option | $58.34 | A | 17157 | Acquired | 2030-04-01 | Common Stock (17157) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $74.29 | 2021-04-01 | Common Stock (5350) | 5350 | Direct |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (6059) | 6059 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (7044) | 7044 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (9050) | 9050 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (7513) | 7513 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (24240) | 24240 | Direct |
Footnotes
F1: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards.
F2: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2021.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
F4: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.
F5: Options became exercisable in four equal annual installments beginning on 4/1/2016.
F6: Options became exercisable in four equal annual installments beginning on 4/1/2017.
F7: Options became exercisable in four equal annual installments beginning on 4/3/2018.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2019.
F9: Options became exercisable in four equal annual installments, commencing 4/1/2020.